Log in

NYSE:MMIMarcus & Millichap Stock Price, Forecast & News

$28.18
-0.21 (-0.74 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.06
Now: $28.18
$29.28
50-Day Range
$23.94
MA: $28.33
$31.60
52-Week Range
$21.90
Now: $28.18
$38.24
Volume81,571 shs
Average Volume145,146 shs
Market Capitalization$1.11 billion
P/E Ratio14.99
Dividend YieldN/A
Beta1.11
Marcus & Millichap, Inc., a brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada. The company offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, and industrial properties, as well as hospitality, self-storage, seniors housing, land, and manufactured housing properties. It also operates as a broker of debt financing for commercial properties. In addition, the company provides various ancillary services, including research, and advisory and consulting services to developers, lenders, owners, real estate investment trusts, high net worth individuals, pension fund advisors, and other institutions. Marcus & Millichap, Inc. was founded in 1971 and is headquartered in Calabasas, California.
Read More
Marcus & Millichap logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.8Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.62 out of 5 stars


Industry, Sector and Symbol

Industry Real estate agents & managers
Sub-IndustryN/A
SectorFinance
CUSIPN/A
Phone818-212-2250

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$806.43 million
Cash Flow$2.69 per share
Book Value$12.65 per share

Profitability

Net Income$76.93 million

Miscellaneous

Employees831
Market Cap$1.11 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive MMI News and Ratings via Email

Sign-up to receive the latest news and ratings for MMI and its competitors with MarketBeat's FREE daily newsletter.

Marcus & Millichap (NYSE:MMI) Frequently Asked Questions

How has Marcus & Millichap's stock been impacted by COVID-19 (Coronavirus)?

Marcus & Millichap's stock was trading at $27.23 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MMI stock has increased by 3.5% and is now trading at $28.18. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Marcus & Millichap?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Marcus & Millichap in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Marcus & Millichap.

When is Marcus & Millichap's next earnings date?

Marcus & Millichap is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Marcus & Millichap.

How were Marcus & Millichap's earnings last quarter?

Marcus & Millichap Inc (NYSE:MMI) released its earnings results on Thursday, May, 7th. The real estate investment trust reported $0.33 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.31 by $0.02. The real estate investment trust had revenue of $190.70 million for the quarter, compared to the consensus estimate of $167.80 million. Marcus & Millichap had a net margin of 8.89% and a return on equity of 15.44%. Marcus & Millichap's revenue was up 18.7% on a year-over-year basis. During the same period last year, the company posted $0.40 earnings per share. View Marcus & Millichap's earnings history.

What price target have analysts set for MMI?

2 brokerages have issued twelve-month target prices for Marcus & Millichap's shares. Their forecasts range from $28.00 to $28.00. On average, they anticipate Marcus & Millichap's share price to reach $28.00 in the next twelve months. This suggests that the stock has a possible downside of 0.6%. View analysts' price targets for Marcus & Millichap.

Has Marcus & Millichap been receiving favorable news coverage?

Headlines about MMI stock have been trending somewhat negative recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Marcus & Millichap earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave headlines about the real estate investment trust a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Marcus & Millichap.

Are investors shorting Marcus & Millichap?

Marcus & Millichap saw a increase in short interest in June. As of June 15th, there was short interest totaling 622,600 shares, an increase of 7.9% from the May 31st total of 577,200 shares. Based on an average daily trading volume, of 180,900 shares, the days-to-cover ratio is presently 3.4 days. Approximately 2.7% of the shares of the company are sold short. View Marcus & Millichap's Current Options Chain.

Who are some of Marcus & Millichap's key competitors?

What other stocks do shareholders of Marcus & Millichap own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marcus & Millichap investors own include Jones Lang LaSalle (JLL), CBRE Group (CBRE), HFF (HF), Newmark Group (NMRK), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Colliers International Group (CIGI), General Electric (GE) and Walker & Dunlop (WD).

Who are Marcus & Millichap's key executives?

Marcus & Millichap's management team includes the following people:
  • Mr. George M. Marcus, Co-Founder & Co-Chairman (Age 78)
  • Mr. William A. Millichap, Co-Founder & Co-Chairman (Age 75)
  • Mr. Hessam Nadji, Pres, CEO & Director (Age 54)
  • Mr. Martin E. Louie, Sr. VP & CFO (Age 58)
  • Mr. Mitchell R. LaBar, Exec. VP & COO (Age 59)

What is Marcus & Millichap's stock symbol?

Marcus & Millichap trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMI."

Who are Marcus & Millichap's major shareholders?

Marcus & Millichap's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Reinhart Partners Inc. (1.79%). Company insiders that own Marcus & Millichap stock include George M Marcus, Hessam Nadji, Martin E Louie, Mitchell R Labar and Phoenix Investments Holdings L. View institutional ownership trends for Marcus & Millichap.

Which major investors are buying Marcus & Millichap stock?

MMI stock was bought by a variety of institutional investors in the last quarter, including Reinhart Partners Inc.. View insider buying and selling activity for Marcus & Millichap.

How do I buy shares of Marcus & Millichap?

Shares of MMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Marcus & Millichap's stock price today?

One share of MMI stock can currently be purchased for approximately $28.18.

How big of a company is Marcus & Millichap?

Marcus & Millichap has a market capitalization of $1.11 billion and generates $806.43 million in revenue each year. The real estate investment trust earns $76.93 million in net income (profit) each year or $1.95 on an earnings per share basis. Marcus & Millichap employs 831 workers across the globe.

What is Marcus & Millichap's official website?

The official website for Marcus & Millichap is www.marcusmillichap.com.

How can I contact Marcus & Millichap?

Marcus & Millichap's mailing address is 23975 PARK SORRENTO SUITE 400, CALABASAS CA, 91302. The real estate investment trust can be reached via phone at 818-212-2250 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.